Form EFFECT Adverum Biotechnologies,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 |
| Accession Number: | 0001193125-25-312795 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Invitation to Minesto's webinar: Q3 update by CEO
- Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
- The Top 10 Best Self-Publishing Companies of 2026: Transform a Manuscript Into a Bestseller With the Right Partner
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share